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genotype–phenotype correlation difficult. As far as
we know, this is one of the smallest duplications
associated with BWS and is consistent with the
independent regulation of ICR1 and ICR2. Our
patient presented moderate developmental delay and
craniofacial features typical of 11p15 duplication.
Future studies exploiting this subtle 11p15.5 rear-
rangement will provide an important tool to further
dissecting the genomics of BWS region and the
pathogenesis of this imprinting disorder.
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In several laboratories, genome-wide array analysis is
already the first-tier diagnostic test for the identifica-
tion of copy number changes in patients with mental
retardation and/or congenital anomalies. The identifi-
cation of a pathogenic copy number variant (CNV) is
important not only to make a proper diagnosis but
also to enable the accurate estimation of the recur-
rence risk to family members. Upon the identification
of a de novo interstitial loss or gain, the recurrence
risk is considered very low. Nevertheless, apparently,
de novo imbalances in a patient can be the conse-
quence of the unbalanced transmission of a derivative
chromosome involved in an insertional translocation
(IT) in one of the parents. To determine the frequency
with which insertional balanced translocations would
be the origin of submicroscopic imbalances in a total
of 10,459 patients with developmental abnormalities,
we investigated the potential presence of an inser-
tional translocation in a consecutive series of 419 de
novo interstitial CNVs. We demonstrate that inser-
tional translocations underlie approximately 1.5% of
the apparently de novo CNVs, indicating that submi-
croscopic ITs are at least 40-fold more frequent than
cytogenetically visible ITs (0.04%). This risk estimate
should be taken into account during counselling and
warrant parental testing in patients with a de novo
interstitial aberration.
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Tricho-rhino-phalangeal syndrome type I (TRPS I;
OMIM 190350) and type II (OMIM 150230) are two
forms of the rare autosomal-dominant TRP malfor-
mation syndrome localised in 8q23.3–24.1. TRPS I is
generally caused by point mutations or deletions of
the TRPS1 gene, whereas type II is characterised by
the presence of multiple cartilage exostoses (EXT)
and deletions comprising the TRPS1 and EXT1 genes.
In the present study, we have mapped and sequenced
the breakpoints of a balanced familial translocation [t
(8;13)(q23.3;q21.32)] segregating with mild TRPS I
and analysed the TRPS1 candidate gene. The pro-
band, in addition to features compatible with TRPS I,
also presented developmental delay and severe mental
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retardation. The pathogenic chromosome 8 breakpoint
was localised within a transposon type I element at
116.768 Mb, 87 kb from the TRPS1 5′ end. The
breakpoint on chromosome 13 was localised within a
gene-poor region at 65.101 Mb, and the nearest gene,
1.5 Mb distal from the breakpoint, is protocadherin 9
(PCDH9). Analysis of the three affected relatives by
the 33K tiling BAC array and of the proband by 2.7-
M high-resolution oligonucleotide array painting did
not reveal additional genomic variation. Furthermore,
mutation screening of the TRPS1 also did not reveal
any alteration. Finally, expression studies of TRPS1
performed from LCLs indicate that inter-individual
variation is higher than the expected gene expression
changes induced by the translocation. Although the
reason underlying the severe mental retardation
observed in the proband is unknown, the available
data indicate that this is not associated with the
translocation. As far as we know, this is the first
reported case of position effect or “cis-ruption”
causing TRPS I. Finally, further studies are necessary
to unveil the molecular pathogenic mechanisms of
this “cis-ruption disorder” triggered by chromosome
translocation.
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SATB2 is an AT-rich sequence-binding protein that
binds to nuclear matrix attachment regions. It plays an
important role in transcription regulation and chro-
matin loop remodelling. Deletions, chromosome
translocations, as well as heterozygous nonsense
mutations affecting this gene have been reported
associated with overlapping conditions involving
craniofacial anomalies such as the isolated cleft
palate (OMIM 119540), 2q33.1 microdeletion syn-
drome (OMIN 612313) and Toriello–Carey syn-
drome (OMIM 217980). The aim of this study was
the identification of the breakpoint sequences and
candidate gene/s of a de novo t(1;2)(q14.1;q35)
associated with severe mental retardation, behaviour
disturbance, dysmorphic facies, dental anomalies,
convergent strabismus and high palate but without
clefting. The chromosome 2 breakpoint is localised
at position 199,567,382 of the current human
genome assembly (hg19), within IVS1 of the
processed transcript AC019330.1. This breakpoint
disrupts an evolutionarily conserved non-coding
genomic element localised 566.8 kb from the 3′
end of the SATB2 gene. The chromosome 1 break-
point is localised within IVS13 of the zyg-11
homolog A (Caenorhabditis elegans) ZYG11A gene,
at position 53,355,744 (assembly hg19). Although
the chromosome 1 breakpoint disrupts the ZYG11A,
we consider that the SATB2 is the main candidate
gene, which is substantiated by the overlap observed
between the probands’ phenotype with the patholo-
gies associated with this gene. The characterization
of the translocation breakpoints allowed us to
establish an accurate clinical diagnosis. As patho-
genic mechanism, we propose the disruption of the
genomic architecture of evolutionary conserved
long-range regulatory elements leading to a so-
called cis-ruption disorder. The elucidation of the
pathogenic mechanism by which disruption of such
an evolutionarily conserved sequence element leads
to the aforementioned condition will allow us to
consider new therapeutic strategies that may hinder
progressive deterioration of the clinical condition in
such “cis-ruption disorders”.
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